Literature DB >> 26727011

Assessment of the MSF triage system, separating patients into different wards pending Ebola virus laboratory confirmation, Kailahun, Sierra Leone, July to September 2014.

Florian Vogt1, Gabriel Fitzpatrick, Gabriela Patten, Rafael van den Bergh, Kathryn Stinson, Luigi Pandolfi, James Squire, Tom Decroo, Hilde Declerck, Michel Van Herp.   

Abstract

Prevention of nosocomial Ebola virus (EBOV) infection among patients admitted to an Ebola management centre (EMC) is paramount. Current Médecins Sans Frontières (MSF) guidelines recommend classifying admitted patients at triage into suspect and highly-suspect categories pending laboratory confirmation. We investigated the performance of the MSF triage system to separate patients with subsequent EBOV-positive laboratory test (true-positive admissions) from patients who were initially admitted on clinical grounds but subsequently tested EBOV-negative (false-positive admissions). We calculated standard diagnostic test statistics for triage allocation into suspect or highly-suspect wards (index test) and subsequent positive or negative laboratory results (reference test) among 433 patients admitted into the MSF EMC Kailahun, Sierra Leone, between 1 July and 30 September 2014. 254 (59%) of admissions were classified as highly-suspect, the remaining 179 (41%) as suspect. 276 (64%) were true-positive admissions, leaving 157 (36.3%) false-positive admissions exposed to the risk of nosocomial EBOV infection. The positive predictive value for receiving a positive laboratory result after being allocated to the highly-suspect ward was 76%. The corresponding negative predictive value was 54%. Sensitivity and specificity were 70% and 61%, respectively. Results for accurate patient classification were unconvincing. The current triage system should be changed. Whenever possible, patients should be accommodated in single compartments pending laboratory confirmation. Furthermore, the initial triage step on whether or not to admit a patient in the first place must be improved. What is ultimately needed is a point-of-care EBOV diagnostic test that is reliable, accurate, robust, mobile, affordable, easy to use outside strict biosafety protocols, providing results with quick turnaround time.

Entities:  

Keywords:  Ebola management centre; Ebola virus; Sierra Leone; admission; suspect case; triage

Mesh:

Year:  2015        PMID: 26727011     DOI: 10.2807/1560-7917.ES.2015.20.50.30097

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  13 in total

Review 1.  Epidemiology and Management of the 2013-16 West African Ebola Outbreak.

Authors:  M L Boisen; J N Hartnett; A Goba; M A Vandi; D S Grant; J S Schieffelin; R F Garry; L M Branco
Journal:  Annu Rev Virol       Date:  2016-08-15       Impact factor: 10.431

2.  Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.

Authors:  Matthew L Boisen; Robert W Cross; Jessica N Hartnett; Augustine Goba; Mambu Momoh; Mohamed Fullah; Michael Gbakie; Sidiki Safa; Mbalu Fonnie; Francis Baimba; Veronica J Koroma; Joan B Geisbert; Stephanie McCormick; Diana K S Nelson; Molly M Millett; Darin Oottamasathien; Abby B Jones; Ha Pham; Bethany L Brown; Jeffrey G Shaffer; John S Schieffelin; Brima Kargbo; Momoh Gbetuwa; Sahr M Gevao; Russell B Wilson; Kelly R Pitts; Thomas W Geisbert; Luis M Branco; Sheik H Khan; Donald S Grant; Robert F Garry
Journal:  J Infect Dis       Date:  2016-08-11       Impact factor: 5.226

3.  An Outbreak of Ebola Virus Disease in the Lassa Fever Zone.

Authors:  Augustine Goba; S Humarr Khan; Mbalu Fonnie; Mohamed Fullah; Alex Moigboi; Alice Kovoma; Vandi Sinnah; Nancy Yoko; Hawa Rogers; Siddiki Safai; Mambu Momoh; Veronica Koroma; Fatima K Kamara; Edwin Konowu; Mohamed Yillah; Issa French; Ibraham Mustapha; Franklyn Kanneh; Momoh Foday; Helena McCarthy; Tiangay Kallon; Mustupha Kallon; Jenneh Naiebu; Josephine Sellu; Abdul A Jalloh; Michael Gbakie; Lansana Kanneh; James L B Massaly; David Kargbo; Brima Kargbo; Mohamed Vandi; Momoh Gbetuwa; Sahr M Gevao; John D Sandi; Simbirie C Jalloh; Donald S Grant; Sylvia O Blyden; Ian Crozier; John S Schieffelin; Susan L McLellan; Shevin T Jacob; Matt L Boisen; Jessica N Hartnett; Robert W Cross; Luis M Branco; Kristian G Andersen; Nathan L Yozwiak; Stephen K Gire; Ridhi Tariyal; Daniel J Park; Allyson M Haislip; Christopher M Bishop; Lilia I Melnik; William R Gallaher; William C Wimley; Jing He; Jeffrey G Shaffer; Brian M Sullivan; Sonia Grillo; Scott Oman; Courtney E Garry; Donna R Edwards; Stephanie J McCormick; Deborah H Elliott; Julie A Rouelle; Chandrika B Kannadka; Ashley A Reyna; Benjamin T Bradley; Haini Yu; Rachael E Yenni; Kathryn M Hastie; Joan B Geisbert; Peter C Kulakosky; Russell B Wilson; Michael B A Oldstone; Kelly R Pitts; Lee A Henderson; James E Robinson; Thomas W Geisbert; Erica Ollmann Saphire; Christian T Happi; Danny A Asogun; Pardis C Sabeti; Robert F Garry
Journal:  J Infect Dis       Date:  2016-07-11       Impact factor: 5.226

Review 4.  Diagnostics in Ebola Virus Disease in Resource-Rich and Resource-Limited Settings.

Authors:  Robert J Shorten; Colin S Brown; Michael Jacobs; Simon Rattenbury; Andrew J Simpson; Stephen Mepham
Journal:  PLoS Negl Trop Dis       Date:  2016-10-27

5.  Bolstering Community Cooperation in Ebola Resurgence Protocols: Combining Field Blood Draw and Point-of-Care Diagnosis.

Authors:  Mosoka P Fallah; Laura A Skrip; Philomena Raftery; Miata Kullie; Watta Borbor; A Scott Laney; David J Blackley; Athalia Christie; Emily Kainne Dokubo; Terrence Q Lo; Stewart Coulter; April Baller; Benjamin T Vonhm; Philip Bemah; Sowillie Lomax; Adolphus Yeiah; Yatta Wapoe-Sackie; Jennifer Mann; Peter Clement; Gloria Davies-Wayne; Esther Hamblion; Caitlin Wolfe; Desmond Williams; Alex Gasasira; Francis Kateh; Tolbert G Nyenswah; Alison P Galvani
Journal:  PLoS Med       Date:  2017-01-24       Impact factor: 11.069

6.  Operational Research during the Ebola Emergency.

Authors:  Gabriel Fitzpatrick; Tom Decroo; Bertrand Draguez; Rosa Crestani; Axelle Ronsse; Rafael Van den Bergh; Michel Van Herp
Journal:  Emerg Infect Dis       Date:  2017-07       Impact factor: 6.883

Review 7.  Strategy and technology to prevent hospital-acquired infections: Lessons from SARS, Ebola, and MERS in Asia and West Africa.

Authors:  Sanjeewa Jayachandra Rajakaruna; Wen-Bin Liu; Yi-Bo Ding; Guang-Wen Cao
Journal:  Mil Med Res       Date:  2017-10-27

8.  Development of a Pediatric Ebola Predictive Score, Sierra Leone1.

Authors:  Felicity Fitzgerald; Kevin Wing; Asad Naveed; Musa Gbessay; J C G Ross; Francesco Checchi; Daniel Youkee; Mohamed Boie Jalloh; David E Baion; Ayeshatu Mustapha; Hawanatu Jah; Sandra Lako; Shefali Oza; Sabah Boufkhed; Reynold Feury; Julia Bielicki; Elizabeth Williamson; Diana M Gibb; Nigel Klein; Foday Sahr; Shunmay Yeung
Journal:  Emerg Infect Dis       Date:  2018-02       Impact factor: 6.883

9.  Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: challenges in the later stages of the 2014 outbreak.

Authors:  Javier Arranz; Karen Marie Lundeby; Shoaib Hassan; Luis Matías Zabala Fuentes; Pedro San José Garcés; Yngvar Lunde Haaskjold; Håkon Angell Bolkan; Kurt Østhuus Krogh; James Jongopi; Sindre Mellesmo; Ola Jøsendal; Åsmund Øpstad; Erling Svensen; Alfred Sandy Kamara; David P Roberts; Paul D Stamper; Paula Austin; Alfredo J Moosa; Dennis Marke; Åse Berg; Bjørn Blomberg; Melcior Riera
Journal:  BMC Infect Dis       Date:  2016-06-22       Impact factor: 3.090

10.  Post-exposure treatment of Ebola virus disease in guinea pigs using EBOTAb, an ovine antibody-based therapeutic.

Authors:  Stuart D Dowall; Andrew Bosworth; Emma Rayner; Irene Taylor; John Landon; Ian Cameron; Ruth Coxon; Ibrahim Al Abdulla; Victoria A Graham; Graham Hall; Gary Kobinger; Roger Hewson; Miles W Carroll
Journal:  Sci Rep       Date:  2016-07-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.